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Abstract
Pathological anxiety is paralleled by deficits in
serotonergic and GABAergic neurotransmission in
the amygdala. Conversely, anxiety disorders and
depression may be reversed by brain-derived
neurotrophic factor (BDNF). BDNF signaling involves
Phosphatidylinositol 3-Kinase / 3-phosphoinositide-
dependent protein kinase 1 (PI3K/PDK1). We thus
hypothesized that impaired function of PDK1 might
be associated with increased anxiety and concomitant
neurotransmitter changes. Here we used the
hypomorphic PDK1hm mouse to investigate anxiety
behavior in different settings: PDK1hm mice differed
from Wt littermates PDK1WT in several behavioral
measures related to anxiety and exploration, namely
in the open field, dark-light box, O-maze and startle
response. Further we analyzed the brain substrate
underlying this phenotype and found significantly
decreased GABA, taurine and serotonin
concentrations in the amygdala and olfactory bulb of
PDK1hm mice, while BDNF and nerve growth factor
(NGF) concentrations were not significantly different
between PDK1hm and PDK1WT mice. These results
suggest that impaired PI3K signaling in the PDK1hm
mouse reduces concentrations of GABA and serotonin
in anxiety related brain regions and can serve as a
molecular substrate for behavior indicative for anxious
and depressive-like mood states.
Introduction
A large body of evidence from rodent studies
indicates that the amygdala plays the central role in the
acquisition and expression of conditioned fear [1] and
recently it has been shown that fear learning in the
amygdala involves brain-derived neurotrophic factor
(BDNF) and Phosphatidylinositol 3-Kinase (PI3K)
activation [2]. Studies in humans have largely confirmed
hypotheses about fear conditioning from animal studies,
where neuroimaging studies demonstrate that the
amygdala is critical for emotional learning in fear
conditioning paradigms [1, 3].
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The BDNF hypothesis of depression and anxiety
postulates that a loss of BDNF is directly involved in the
pathophysiology of depression and anxiety and its
restoration may underlie the therapeutic efficacy of
antidepressant treatments [4, 5]. BDNF affects neuronal
growth, neurogenesis and memory in a PI3K dependent
way [2, 6]. BDNF signaling involves phosphoinositide-
dependent protein kinase 1 (PDK1) [7].
Accordingly, the PI3K signaling pathway has been
shown to regulate hippocampal proliferation,
differentiation and survival, to develop dendrite size and
shape and to induce functional synapses in neuronal cells
[8-10]. Both, pharmacological inhibition and genetic
manipulation of PI3K-dependent signaling demonstrate
that PI3K signals via PDK1 [11]. PDK1 is a direct
downstream effector of PI3K [11] and plays a central
role in activating other downstream processes, including
cell proliferation, survival and differentiation [12].
On the neurotransmitter level, especially serotonin
(5-HT) and GABA have been shown to powerfully
regulate the neuroanatomical circuit that mediates fear
in anxiety disorders [13].
To explore the impact of PDK1 signaling on
transmitter concentrations in amygdala and on behavior,
gene targeted mice were analyzed in the present study.
As the PDK1 knockout mouse is not viable [14], mice
with suppressed PDK1 activity to some 10-25 %
(PDK1hm) [14] were compared to their age and sex
matched wild type littermates (PDK1WT).
Materials and Methods
Animals
The generation and basic properties of PDK1
hypomorphic mice have been described earlier [14, 15].
Genotyping was made by PCR on tail DNA using PDK1 and
neo-R-specific primers as previously described [14]. Mice had
free access to standard mouse diet (Altromin, Langen, Germany)
and tap water. All animal experiments were conducted according
to the guidelines of the American Physiological Society and
the German law for the welfare of animals and were approved
by the local authorities. For the present study 12 PDK1
hypomorphic mice (PDK1hm) and their wild type littermates
(n=16; PDK1WT) were used.
Housing and handling
One week before the experimental period, animals were
transferred to the Institute of Anatomy in Zuerich where they
were single housed in standard type II mouse cages and
maintained at a 12:12 h inverted cycle with lights on between 8
p.m. and 8 a.m. Standard mouse chow, water and nesting material
were available ad libitum. Behavioral testing occurred between
8 a.m. and 8 p.m. Only one type of experiment was done on the
same day and the home cage rack was brought to the test room
at least 30 min before each experiment and dry surfaces of
apparatus were thoroughly cleaned with 70 % ethanol before
releasing the animal. Experiments extended over a total of 6
weeks, average age was 5.6 months at the beginning and 7.5
months at the end of the testing period.
Behavioural studies
For data acquisition, animals were video tracked at 4.2 Hz
and 576x768 pixel spatial resolution using a Noldus EthoVision
3.0 system (Noldus InformationTechnology, Wageningen, The
Netherlands, www.noldus.com). Raw data were transferred to
the public domain software Wintrack 2.4 [16] (www.dpwolfer.ch/
wintrack) for further analysis.
Tests were done in the following order: open-field, LD-
box, O-maze, emergence test, object exploration, and acoustic
startle response profile. Experiments were performed with diffuse
indirect room light produced by 440W bulbs, adjusted to yield
approximately 12 lux in the center of the experimental arena.
The only exception was the LD-box test where full room light
was switched on to obtain approximately 500 lux in the lit
chamber. The experiments have been performed as described
previously in detail [17].
For open-field the round open-field arena had a diameter
of 150 cm, a white plastic floor, and 35 cm high sidewalls made
of white polypropylene. Each subject was released near the
wall and observed for 10 min. The same procedure was repeated
the following day, resulting in a total observation time of 20
min [18].
For the light-dark box a 20x30 cm transparent Perspex
chamber (20 cm high) under direct room light was connected
by a 7.5x7.5 cm aperture to a 20x15x20 cm polyvinyl-chloride
dark box. Each subject was released in the middle of the lit
compartment and observed for 5 min [19].
For O-maze a 5.5 cm wide annular runway was constructed
using grey plastic. It had an outer diameter of 46 cm and was
placed inside the above open-field arena 40 cm above the floor
[17, 20]. The two opposing 90° closed sectors were protected
by 16 cm high inner and outer walls of grey polyvinyl-chloride,
while the remaining two open sectors had no walls. Animals
were released in one of the closed sectors and observed for 10
min.
For the emergence test the procedure was modified after
Dulawa et al. [21]. Frames of non-reflective aluminium (37 cm
high) were used to partition the above open-field into four
square 50x50 cm arenas, allowing for concurrent observation
of 4 animals. Each arena had a 12x8x4 cm plastic home box with
an aperture of 8x4 cm, positioned in a corner at 5 cm from the
nearest walls, with the aperture facing away from the wall. 24 h
prior to testing, a thoroughly cleaned home box was placed in
the home cage of each test subject. The next day, test subjects
and home boxes were introduced into the arenas and observed
for 30 min.
For the object exploration test, the procedure was modified
after Dulawa et al. [21]. Arenas were the same as for the
emergence test, but without the home box. The novel object
was a 12x4 cm semi-transparent 50 ml Falcon tube positioned
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vertically in the center of the arena and fixed with adhesive
tape. Each subject was observed for 30 min in the empty, cleaned
arena. Then, the novel object was introduced and observation
continued for another 30 min.
For acoustic startle response, testing was conducted
using a Hamilton-Kinder SM100 startle monitor system
(www.hamiltonkinder.com, Poway, CA). The rectangular animal
restrainer (3.8x8.8 cm) was made of clear Perspex and had an
adjustable ceiling which was set to prevent the animal from
rearing. The restrainer rested on a sensing plate which carried
a piezoelectric accelerometer at its bottom. The unit was
mounted on a heavy metallic base plate by four mounting pins
and enclosed in a sound-attenuated ventilated cabinet (internal
dimensions 29x29x18 cm). The loudspeaker was located 22 cm
above the animal and produced white noise pulses. A
microcomputer interface controlled the loudspeaker and
performed an A/D conversion of the signals from the
accelerometer. Signal calibration was done using a Newton
impulse calibrator. Sound levels were verified using a digital
sound level meter (Radio Shack). The background noise level
inside the closed cabinet was maintained at 70 dB. Subjects
were placed in the thoroughly cleaned and dried restrainer and
left undisturbed for 5 min before the session began. In total, 66
trials were presented. Nine different sound levels (dB) were
used: 64, 68, 72, 76, 80, 90, 100, 110, and 120 [22]. Each stimulus
was 40 ms and presented 6 times in pseudorandom order such
that each sound level occurred once within a block of 9 trials.
The series began and ended with 6 presentations each of the
120 dB stimulus. The average intertrial interval was 15 s (ranging
from 10 to 20 s). The startle response was recorded for 250 ms
(measuring the response every 1-ms) starting with the onset of
the startle stimulus and the maximum amplitude was used as
the dependent variable.
Dissection of the brains and homogenization procedure
Mice were sacrificed 7 days after the last behavioral
experiment. After decapitation, the brains were rapidly removed,
immediately frozen on dry ice and stored at -80 °C until use. For
dissection the frozen brains were placed on a cold plate
providing a temperature between -10 and -12 °C. At this
temperature the brain tissue was in a semi-frozen state with
well-preserved anatomical structure. The amygdala/piriform
cortex was cut out using the rhinal fissure as landmark. The
olfactory bulb was dissected along the basis of the frontal
cortex. Each tissue sample was homogenized by ultrasonication
in 40-80 volumes of distilled water. For the determination of
NGF and BDNF protein 150 μl of the homogenate were added
to an equal volume of buffer containing 0.1 M Tris-HCl, pH 7.0,
0.4 M NaCl, 0.1% NaN3, and a variety of protease inhibitors
(“complete”-Protease Inhibitor Cocktail Tablets, Roche
Diagnostics GmbH, Penzberg, Germany). For the analysis of
monoamines and metabolites 150 μl of the homogenate were
added to an equal volume of 0.2 M perchloric acid and
centrifuged at 25,000 g for 20 min at 4 °C. 5-HT, 5- hydro-
xyindoleacetic acid (5-HIAA), and the catecholamines
noradrenaline (NA) and dopamine (DA) were measured in the
supernatant [23]. For amino acid analysis 20 μl of the
homogenate were added to 80 μl methanol and centrifuged at
25,000g for 20 min at 4 °C. The supernatant was diluted 1:30
with distilled water.
Determination of NGF and BDNF protein
Endogenous NGF levels in the thawed homogenates were
determined by a fluorometric two-site enzyme immunoassay
(ELISA) which has been described in detail elsewhere [23, 24].
The mean recovery of mouse NGF (125 pg/ml) added to the
homogenate ranged from 60 % to 90 %. NGF content was
expressed as equivalents of mouse 2.5S NGF. The detection
limit of the assay was 0.25 pg/ml.
Endogenous levels of BDNF were measured in the thawed
homogenates using commercial ELISA kits in principle
according to the manufacturer’s instructions (Promega, Inc.)
but adapted to the fluorometric technique also used for NGF
determination [25, 26]. BDNF content was expressed as
equivalents of recombinant human BDNF. The detection limit
of the assay was 1 pg/ml. Each sample (namely each tissue
dissected and homogenized as described above) was
consecutively processed for quantification of each
neurotrophin, i.e., NGF and BDNF [25, 26]. Determinations of
recovery, and specific and unspecific neurotrophin binding
(the latter against mouse IgG1 obtained from MOPC 21) involved
quadruplicate fluorescence determinations for each tissue
sample. The neurotrophin levels were expressed as pg/mg
tissue (wet weight). In order to minimize the influence of
unavoidable variances between experiments, neurotrophin
levels from animals were normalized as a percentage of wildtypes
serving as control, always being included in the same experiment
[23].
Determination of monoamines and metabolites
5-HT and 5-HIAA were analyzed as described previously
using high-performance liquid chromatography (HPLC) with
electrochemical detection [27]. NA and DA were measured by
HPLC with electrochemical detection after extraction to alumina,
according to Felice et al. [28] with minor modifications [29].
Determination of amino acids
Glutamate, γ-amino butyric acid (GABA), and taurine were
determined using methods described previously [30]. In brief,
amino acids were precolumn derivatized with ο-phthalaldehyde-
2-mercaptoethanol using a refrigerated autoinjector and then
separated on a HPLC column (ProntoSil C18 ace-EPS) at a flow
rate of 0.6 mL/min and a column temperature of 40 °C. The
mobile phase was acetonitrile 50 mmol/mL sodium acetate
solution pH = 5.7 in a linear gradient from 5 % to 21 %
acetonitrile. Derivatized amino acids were detected by their
fluorescence at 450 nm and excitation at 330 nm.
Statistics
Data were analyzed using a two-way factorial ANOVA
design with genotype as between subject factor. Where
appropriate, the model was complemented by within subject
factors to explore the dependence of genotype effects on place,
time, and stimulus intensity. One-sample t-tests were used to
compare group means with hypothesized values.
Increased Anxiety in PDK1 Hypomorphic Mice Cell Physiol Biochem 2008;22:735-744
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Where possible, ANOVA main effects were verified using
nonparametric tests which produced similar results. Statview
version 5.0 (SAS Institute, Cary, North Carolina,
www.statview.com) was used for all statistical calculations. The
software Sigma Stat was used for the statistical analysis of
data concerning neurotrophin and metabolite concentrations.
For statistical analysis of the biochemical data the Student’s t-
test was applied.
Results
Body and brain weight
PDK1hm mice appeared healthy, but they were
considerably smaller than their wild type littermates
PDK1WT (16 PDK1WT, 12 PDK1hm, 4.1-10.9 months).
Body weight of PDK1hm mice was significantly lower in
PDK1hm than in PDK1WT mice (p<0.0001, Table 1), which
was the case also for fresh brain weight (p<0.0001,
Table 1. Brain and body weight. (16 Wt, 12 KO, cohort 1 4.9-
11.8 months), factorial ANOVA. Type I error p-values are shown
for all effects if <0.1, followed by estimated effect sizes shown
as partial omega squared, the proportion of variance accounted
for by genotype, if only this factor were in the design (range 0
to 1.0). Up and down arrows indicate direction of mean
differences if type I error p<0.25.
Fig. 1. Acoustic startle response profile (16 Wt, 12 PDK1hm,
4.1 - 10.9 months). Startle response amplitude to stimuli of 68,
72, 76, 80, 90, 100, 110, 120 dB. The response profile of PDK1hm
tended to be shifted to the right, indicating a possible threshold
increase (genotype F(1.24) = 3.9 p<0.0610, stimulus F(7.168) =
54.0 p<0.0001, genotype x stimulus F(7.168)=1.2 ns; * significant
genotype effect at individual SPL after correction for multiple
comparisons according to false discovery rate control procedure
of Benjamini and Hochberg.
Fig. 2. Open field (16 Wt, 12 PDK1hm, 3.7 - 10.6 months). A.
Distance traveled during the first and second 5 minutes during
the first and second day. Even though the plot suggests that
PDK1hm were less active than Wt during the first 5 min on each
day, the time course of activity is statistically indistinguishable
between groups (genotype F(1.24) = 0.8 ns, time F(3.72) = 14.9
p<0.0001, genotype x time F(3.72) = 1.3 ns). B. Time spent in the
center, transition and wall zone. Both groups avoided the center
and transition zones in favor of the wall zone. PDK1hm tended
to prefer the wall zone slightly more than controls. (zone F(2.48)
= 308.7 p<0.0001, genotype x zone F(2.48) = 2.8 p<0.0682).
Fig. 3. Light/dark box (16 Wt, 12 PDK1hm, 3.8 - 10.7 months).
Time spent inside dark compartment. Mice showed a clear
preference for the dark compartment (genotype F(1.24) = 2.1
ns, one-sample t-test against chance value of 50 % t(27) = 5.9
p<0.0001).
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Fig. 4. O-maze (16 Wt, 12 KO, cohort 1 3.8 - 10.7 months). A.
Time spent on open / closed sectors and in the transition zone.
Both groups strongly avoided the open sectors. KO spent
more time on the closed sector than Wt who preferred to stay
in the transition zone. (zone F(2,48) = 0.4 p<0.0001, genotype x
zone F(2,48) = 5.7 p<0.0062; genotype by zone: open F(1,24) =
0.5 ns, transition F(1,24)=6.9 P<0.0148, closed F(1,24)=6.0
p<0.0224). B. Number of head dips. KO mice performed less
protected head dips. The number of unprotected head dips did
not differ from Wt (genotype F(1,24) = 2.1 ns, zone F(1,24) =
81.3 p<0.0001, genotype x zone F(1,24) = 9.0 p<0.0061; genotype
by zone: unprotected F(1,24) = 0.1 ns, protected F(1,24) = 5.1
p<0.0337).
Fig. 5. Emergence test (16 Wt, 12 PDK1hm, 3.9 - 10.8 months).
A. Distance moved in 10 min. PDK1hm showed the same initial
activity as Wt but female PDK1hm habituated less than Wt
(genotype F(1.24) = 0.5 ns, time F(2.48) = 14.5 p<0.0001, geno-
type x time F(2.48) = 2.5 p<0.0895). B. Time spent in the center,
wall and home zone. Both groups avoided the center zone and
preferred to stay in the zone surrounding the home box (zone
F(2.48) = 18.8 p<0.0001 genotype x zone F(2.48) = 0.8 ns).
Fig. 6. Object exploration (16 Wt, 12 PDK1hm, 3.9 - 10.8 months).
Distance moved in 10 min. PDK1hm did not habituate during
period before insertion of the object and were more active than
Wt while the object was present (genotype F(1.24) = 3.6
p<0.0690, time F(5.120) = 10.9 p<0.0001, genotype x time F(5.115)
= 3.5 p<0.0055, * genotype p<0.05 for split ANOVA at single
time points).
Table 1). The weight of PDK1hm mice amygdala was
significantly less in PDK1hm than in PDK1WT mice (17.73
± 0.58 mg/1000μl; 23.63 ± 0.51 mg/1000μl; p<0.001),
which was the case also for the olfactory bulb (17.68 ±
0.39 mg/1000μl; 24.18 ± 0.55 mg/1000μl; p<0.001). The
relation between reduction of brain and body weight was
not significantly different between PDK1hm and PDK1WT
mice (Table 1).
Behavioral studies
In the acoustic startle response profile, the response
profile of PDK1hm tended to be shifted to the right,
indicating a threshold increase (genotype F(1.24) = 3.9
p<0.0610, stimulus F(7.168) = 54.0 p<0.0001, genotype x
stimulus F(7.168) = 1.2 ns) (Figure 1).
In the open field, no overt differences of spontaneous
behavior have been detected between genotypes, but there
was a trend for PDK1hm mice to spend less time in the
center field (Figure 2).
In the LD-box, light-dark transitions were
significantly less frequent in PDK1hm than in PDK1WT
mice, without significant differences between genotypes
in the total amount of time spent in the dark (Figure 3).
On the O-maze, PDK1hm spent more time than
PDK1WT mice inside the protected sectors and displayed
less risk assessment at the transition between closed and
open sectors (Figure 4).
In the emergence test and object exploration (open
field with home box and additionally a novel object)
PDK1hm mice showed, as compared to PDK1WT mice,
increased activity towards the object and spent more time
inside the home box, but showed normal exploratory
activity while outside the box (Figure 5, 6).
Neurotransmitter concentrations
In the amygdala, PDK1hm mice had, as compared to
PDK1WT mice, lower 5-HT concentrations (Table 2,
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p = 0.034) and an increased 5-HT turnover as indicated
by the molar ratio of 5-HIAA to 5-HT (Table 2, p = 0.046).
The NA content was increased in PDK1hm mice (Table
2, p=0.017). GABA and taurine concentrations in the
amygdala were lower in PDK1hm than in PDK1WT mice
(Table 2, p = 0.015, p = 0.023), whereas glutamate and
DA were not significantly different between genotypes.
BDNF and NGF concentrations in the amygdala were
not significantly different between PDK1hm and PDK1WT
(Table 2).
In the olfactory bulb, 5-hydroxyindoleacetic acid
concentrations were higher in PDK1hm mice than in
PDK1WT mice (Table 3, p = 0.047) but 5-HT
concentrations were not significantly different between
PDK1hm and PDK1WT. NA concentration was
significantly larger in PDK1hm than in PDK1WT mice (Table
3, p = 0.010). In the olfactory bulb GABA and taurine
concentrations were lower in PDK1hm than in PDK1WT
mice (Table 3, p = 0.019, p = 0.021). Glutamate and DA
concentrations in the olfactory bulb were not significantly
different between PDK1hm and PDK1WT mice. Also
BDNF and NGF concentrations in the olfactory bulb were
not significantly different between PDK1hm and PDK1WT.
Discussion
This first behavioral examination of the PDK1hm
phenotype revealed increased anxiety behavior in several
different tests, i.e. open field, light dark box and zero maze
test, which was accompanied by changes of GABA, NA
and 5-HT concentrations in the amygdala and olfactory
bulb.
As reported earlier [14], body weight in PDK1hm
was significantly reduced, which was proportional to
decreases in brain weight. This decrease appears to be
primarily due to decreased cell volume rather than
reduction of cell number [14]. Amongst other factors cell
volume and brain metabolism are determined by cellular
uptake of amino acids [31]. The influence of PDK1
deficiency on brain neurotransmitter abundance and
anxiety behavior could thus be related to altered amino
acid transport. PDK1 activates the serum and
glucocorticoid inducible kinase and protein kinase B PKB/
Akt isoforms [32], which in turn have been shown to
regulate a wide variety of transporters [33]. Previous
experiments in PDK1hm mice indeed revealed a decreased
activity of glucose transporters [34] and amino acid
transporters [35]. Moreover, an increased fluid and food
intake has been reported in PDK1hm mice, while urinary
excretion of glutamate and tryptophan, but not
5-hydroxytryptophan is increased in PDK1hm mice [35].
However, plasma concentrations of these cerebrally
relevant amino acids (glutamate, tryptophan, glycine) in
PDK1hm mice did not differ significantly from those of
PDK1WT mice [35]. Similarly, DA and glutamate
concentrations in amygdala and olfactory bulb were not
significantly different between PDK1hm and PDK1WT mice
(Table 2, 3).
In our study, PDK1hm mice differed from Wt
littermates in several behavioral measures related to
anxiety and exploration (Figure 2-4). In the emergence
test (open field with home box), PDK1hm spent more time
inside the home box, but showed normal exploratory
activity while outside the box (Figure 5, 6). This observed
normal exploratory activity in the emergence test does
not fit to increased anxiety behavior but might be
explained by agitation [36-38].
Increased anxiety behavior in PDK1hm mice can be
linked to decreased activation of the PI3K/Akt pathway,
which has been shown to contribute to mechanisms of
synaptic plasticity and memory consolidation by promoting
Table 2. Neurotransmitter and neurotrophin concentrations
in the amygdala. Data are presented as means ± SEM. The
levels of 5-HT, 5-HIAA, NA, DA, NGF and BDNF are expressed
as pg/mg tissue, the levels of GABA, glutamate and taurine as
pmol/mg tissue.
Table 3. Neurotransmitter and neurotrophin concentrations
in the olfactory bulb. Data are presented as means ± SEM. The
levels of 5-HT, 5-HIAA, NA, DA, NGF and BDNF are expressed
as pg/mg tissue, the levels of GABA, glutamate and taurine as
pmol/mg tissue.
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cell survival and synapse number [9, 39]. After activation
of PI3K, PDK1 is activated leading to phosphorylation
of PKB/Akt. Activated PKB/Akt phosphorylates
intracellular substrates, promoting cell survival by inhibiting
apoptosis through several targets, including Forkhead
transcription factors and mammalian target of rapamycin
[9]. One of the essential functions of PKB/Akt is the
phosphorylation of glycogen synthase kinase 3 GSK-3
causing its inactivation and activation of cAMP response
element binding protein (CREB) [10]. Decreased CREB
function in the central amygdala has been involved in
anxiety behavior [40, 41] and a decreased CREB
phosphorylation after BDNF antisense infusion has been
found [42], which might be attributable to decreased PI3K
activity. Recently, it has been shown that fear learning in
the amygdala involves BDNF and PI3K activation [2].
A role for the PI3K signaling cascade in anxiety
behavior is plausible as several factors influencing anxiety
behavior act via PI3K. Recently, it was demonstrated in
vivo that anxiolytic cannabinoids activate the PI3K/Akt
pathway and negatively regulate GSK-3β activity in the
mouse brain [43]. Also insulin-like growth factor-1 (IGF-
I) and estrogen have been shown to disrupt anxiety
behavior and to activate PI3K [44-46]. Moreover
exercise, with its well known anxiolytic properties,
activates PI3K pathway [47, 48]. BDNF has also been
related to anxiety behavior [49, 50] and fear conditioning
especially in the amygdala [2, 51, 52] and BDNF acts via
PI3K [53, 54]. In this context, we expected a
compensatory upregulation of BDNF and NGF in PDK1hm
which was, however, not observed (Table 2, 3). It should
be kept in mind that PI3K signaling in PDK1hm mice is
not completely abrogated but PDK1 activity is suppressed
by up to 80 % [14]. The residual PDK1 activity may be
sufficient to prevent upregulation of BDNF. In any case,
our findings of increased anxiety connected with deficient
PI3K signaling, suggest that BDNF could influence anxiety
at least in part via a PI3K dependent mechanism.
Moreover, several factors regulating PI3K activity
might converge and exert additive effects, or, if absent,
increase vulnerability. In line with this hypothesis
heterozygous neuregulin 1 mice are more sensitive to
behavioral effects of cannabinoids [55]. Additive genetic
effects of BDNF and 5-HT transporters are dependent
on estrogen modulation, thereby estrogen seems to
compensate BDNF deficiency regarding behavior and
brain monoamine levels [56]. Moreover, running exercise-
and antidepressant-induced increases in growth and
survival-associated signaling molecules are
IGF-dependent [57].
Interestingly, the increased anxiety behavior in
PDK1hm mice was accompanied by a significant decrease
of GABA, taurine and 5-HT in the amygdala, suggesting
an involvement of these neurotransmitters in the
determination of behavioral disturbances (Table 2).
Moreover, 5-HT turnover was increased in the amygdala
and seemed to be also increased in the olfactory bulb,
suggested by increased concentration of 5-HIAA (Table
2, 3). Also in the olfactory bulb a decrease of GABA and
taurine has been observed (Table 3). In both examined
brain regions NA concentrations were increased
(Table 2, 3).
A large body of evidence from rodent and human
neuroimaging studies indicates that the amygdala plays a
critical role in the acquisition and expression of fear
behaviour [1, 3], which may explain that neurotransmitter
changes in anxious PDK1hm occur in this brain region.
Also the olfactory bulb has been implicated in anxiety
behavior [58]. Olfactory bulbectomy has been suggested
as an animal model of comorbid anxiety and leads to
hyperexcitability of amygdala neurons [58, 59]. Indeed,
olfactory information converges in the amygdala, where
the involvement of PI3K signaling has recently been
observed in fear learning [2].
A decreased GABA concentration in amygdala and
olfactory bulb fits well to the concept that GABA is the
principal inhibitory neurotransmitter in the mammalian
brain and its receptors are key control elements of anxiety
states. The concept is based on the anxiolytic properties
of benzodiazepines, which act as allosteric GABA
receptor agonists [60]. Recently, first evidence for a
control of GABAergic function through PI3K-mediated
pathways has been reported [61]. Moreover, the
additional observation of decreased taurine in both brain
areas as observed in PDK1hm mice is in line with the role
of taurine as an anxiolytic-like amino acid after single
and repeated administration and its modulation of
amygdala associated anxiety [62, 63].
5-HT is believed to be the most relevant
neurotransmitter in mediating anxiety [64]. Therefore,
decreased 5-HT concentrations in the amygdala as found
in our PDK1hm mice might well explain increased anxiety
behavior. The amygdala is overactive in patients with
anxiety disorders and chronic administration of 5-HT
reuptake inhibitors normalize amygdalar activity and are
the treatment of choice in anxiety disorders [65-67].
The observed decreases of taurine concentrations
in amygdala and olfactory bulb of PDK1hm mice are
similarly in line with increased anxiety behavior in
PDK1hm mice. In rats taurine microinjections in the
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amygdala have been shown to reduce anxiety behavior
[63] and an anxiolytic effect of taurine (i.p.) was
 also observed in mice [62].
The present study does not address the mechanisms
underlying the influence of PDK1 on neurotransmitter
levels. It is noteworthy, though, that PI3K signaling has
been shown to participate in the regulation of  GABA
transport [68, 69], and the taurine transporter [68, 70-
72]. Kinases activated by PDK1 include the serum and
glucocorticoid inducible kinase (SGK) and protein kinase
B PKB/Akt isoforms, which have been shown to regu-
late a wide variety of channels and transporters including
glutamate transporters and glutamate receptors [33, 73-
82]. Moreover, SGK and PKB phoshorylate and thus in-
hibit glycogen synthase kinase GSK3β [83], which plays
a pivotal role in the regulation of  behaviour [84-86]. Re-
duced locomotion reminiscent of the PDK1 hypomorphic
mouse has been observed in SGK3 deficient mice [17].
In conclusion, we postulate that decreased PI3K
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